NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$19.96
-$0.10 (-0.50%)
Nov 2, 2026, 11:24 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.12M | 22.57M | 22.5M | 35.24M | 64.01M | 47.14M | 45.56M | 33.59M | 7.42M | 6.86M | 14.09M | 18.79M | 21.36M | 68.62M | 111.71M | 106.2M | 100.7M | 51.72M | n/a | n/a | n/a | n/a |
Cost of Revenue | 559K | 559K | 59K | n/a | n/a | n/a | 15K | 15K | 15K | 15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 6.56M | 22.01M | 22.44M | 35.24M | 64.01M | 47.14M | 45.55M | 33.58M | 7.41M | 6.85M | 14.09M | 18.79M | 21.36M | 68.62M | 111.71M | 106.2M | 100.7M | 51.72M | n/a | n/a | n/a | n/a |
Operating Income | -244.41M | -215.18M | -225.68M | -202.93M | -172.79M | -189.73M | -175.76M | -183.6M | -208.16M | -198.07M | -182.97M | -159.96M | -138.47M | -67.9M | 1.61M | 11.67M | 22.46M | -5.94M | -41.43M | -23.55M | -10.06M | -13.54M |
Interest Income | 23.03M | 24.28M | 27.59M | 25.6M | 23.33M | 21.15M | 16.88M | 14.92M | 13.22M | 12.58M | 10.36M | 7.84M | 5.8M | 1.68M | 823.18K | 826.09K | 120.66K | 24.83K | 16.16K | 14.09K | 12.32K | 5.3K |
Pretax Income | -259.5M | -212.73M | -203.82M | -221.07M | -165.72M | -187.36M | -241.6M | -198.89M | -229.38M | -228.66M | -176.91M | -165.49M | -156.4M | -89.55M | -17.38M | 534.97K | 27.51M | -2.35M | -38.06M | -17.89M | -11.01M | -13.9M |
Net Income | -259.5M | -212.73M | -203.82M | -221.07M | -165.72M | -187.36M | -241.6M | -198.92M | -229.4M | -228.69M | -176.94M | -165.49M | -156.4M | -89.55M | -17.38M | 534.97K | 27.51M | -2.35M | -38.06M | -17.89M | -8.25M | -8.39M |
Selling & General & Admin | 102.22M | 102.59M | 106.3M | 103.25M | 96M | 84.04M | 70.79M | 55.19M | 47.04M | 41.6M | 34.53M | 31.02M | 27.09M | 22.1M | 20.4M | 17.06M | 12.51M | 7.95M | 3.63M | 1.91M | 1.6M | 1.65M |
Research & Development | 148.75M | 134.59M | 141.83M | 138.13M | 142.86M | 153.73M | 151.41M | 157.8M | 165.47M | 161.43M | 159.42M | 146.51M | 131.51M | 113.19M | 89.69M | 71.19M | 52.36M | 36.34M | 24.43M | 14.56M | 6.02M | 7.04M |
Other Expenses | n/a | n/a | n/a | -3.21M | -2.07M | -893K | -893K | 4.19M | 3.06M | 1.88M | 3.1M | 1.23M | 1.23M | 1.23M | n/a | 6.28M | 13.37M | 13.37M | 13.37M | 7.08M | -2.72M | -5.43M |
Operating Expenses | 250.97M | 237.18M | 248.13M | 238.18M | 236.8M | 236.87M | 221.31M | 217.18M | 215.57M | 204.91M | 197.06M | 178.75M | 159.82M | 136.52M | 110.1M | 94.54M | 78.24M | 57.66M | 41.43M | 23.55M | 4.91M | 3.25M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.73M | 2.69M | 5.79M | 6.94M | 5.26M | 4.3M | 1.2M | 49.99K | n/a | n/a | n/a | n/a | n/a | 86K | 172K |
Selling & Marketing Expenses | n/a | n/a | n/a | -11.14M | -7.6M | -4.08M | -4.08M | 8.9M | 6.49M | 3.44M | 4.06M | 3.39M | 2.8M | 2.65M | 2.38M | 1.69M | 1.61M | 1.29M | 966.75K | 489.58K | 22.68K | 25.43K |
Cost & Expenses | 251.53M | 237.74M | 248.19M | 238.18M | 236.8M | 236.87M | 221.32M | 217.2M | 215.58M | 204.93M | 197.06M | 178.75M | 159.82M | 136.52M | 110.1M | 94.54M | 78.24M | 57.66M | 41.43M | 23.55M | 10.06M | 13.54M |
Income Tax Expense | n/a | n/a | n/a | n/a | -1K | -1K | -1K | 26K | 27K | 27K | 27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 123.37M | 121.1M | 114.4M | 119M | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 88.38M | 82.48M | 82.48M | 81.85M | 81.63M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
Shares Outstanding (Diluted) | 123.37M | 121.1M | 114.4M | 119M | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 88.38M | 82.48M | 82.48M | 81.85M | 81.63M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
EPS (Basic) | -2.18 | -1.81 | -1.75 | -2.08 | -1.65 | -1.91 | -2.63 | -2.17 | -2.55 | -2.57 | -1.98 | -3.66 | -3.37 | -3.01 | -2.46 | -0.21 | 0.16 | 0.15 | 0.24 | 0.19 | 0.07 | 0.13 |
EPS (Diluted) | -2.18 | -1.81 | -1.75 | -2.08 | -1.65 | -1.91 | -2.63 | -2.17 | -2.55 | -2.57 | -1.98 | -3.66 | -3.37 | -3.01 | -2.46 | -0.21 | 0.16 | 0.15 | 0.24 | 0.19 | 0.07 | 0.13 |
EBITDA | -254.88M | -212.5M | -203.6M | -240.43M | -192.33M | -226.39M | -241.85M | -181.14M | -203.46M | -187.26M | -170.94M | -157.95M | -149.83M | -86.07M | -17.28M | 8.36M | 34.89M | 6.01M | -30M | -17.61M | -7.45M | -8.49M |
EBIT | -255.15M | -212.73M | -203.82M | -240.64M | -192.5M | -226.54M | -241.96M | -181.22M | -203.52M | -187.31M | -170.99M | -157.99M | -149.86M | -86.11M | -17.33M | 8.31M | 34.85M | 5.98M | -30M | -17.61M | -7.45M | -8.5M |
Depreciation & Amortization | 274K | 230K | 220K | 212K | 176K | 150K | 113K | 75K | 61K | 55K | 49K | 38.25K | 31.63K | 37.49K | 48.41K | 47.74K | 41.52K | 22.66K | 3.92K | 2.58K | 1.67K | 1.92K |
Add to Watchlist
Select watchlists to add or remove NAMS